Works matching DE "CHLORAMBUCIL"


Results: 174
    1
    2
    3
    4

    Small Animal Review.

    Published in:
    UK-Vet Companion Animal, 2013, v. 18, n. 9, p. 414, doi. 10.12968/coan.2013.18.9.414
    By:
    • Tennant, Bryn
    Publication type:
    Article
    5
    6

    Small Animal Review.

    Published in:
    UK-Vet Companion Animal, 2013, v. 18, n. 7, p. 302, doi. 10.12968/coan.2013.18.7.302
    By:
    • Tennant, Bryn
    Publication type:
    Article
    7
    8
    9
    10
    11

    Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study.

    Published in:
    Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1033413
    By:
    • Visentin, Andrea;
    • Mauro, Francesca Romana;
    • Catania, Gioachino;
    • Fresa, Alberto;
    • Vitale, Candida;
    • Sanna, Alessandro;
    • Mattiello, Veronica;
    • Cibien, Francesca;
    • Sportoletti, Paolo;
    • Gentile, Massimo;
    • Rigolin, Gian Matteo;
    • Quaglia, Francesca Maria;
    • Murru, Roberta;
    • Gozzetti, Alessandro;
    • Molica, Stefano;
    • Marchetti, Monia;
    • Pravato, Stefano;
    • Angotzi, Francesco;
    • Cellini, Alessandro;
    • Scarfò, Lydia
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20

    The UK NCRI study of chlorambucil, mitoxantrone and dexamethasone (CMD) versus fludarabine, mitoxantrone and dexamethasone (FMD) for untreated advanced stage follicular lymphoma: molecular response strongly predicts prolonged overall survival.

    Published in:
    British Journal of Haematology, 2020, v. 190, n. 4, p. 545, doi. 10.1111/bjh.16555
    By:
    • Bishton, Mark J.;
    • Rule, Simon;
    • Wilson, William;
    • Turner, Deborah;
    • Patmore, Russell;
    • Clifton‐Hadley, Laura;
    • McMillan, Andrew;
    • Lush, Richard;
    • Haynes, Andrew
    Publication type:
    Article
    21

    Outcome of patients aged 80 years or older treated for chronic lymphocytic leukaemia.

    Published in:
    British Journal of Haematology, 2018, v. 183, n. 5, p. 727, doi. 10.1111/bjh.15604
    By:
    • Al‐Sawaf, Othman;
    • Bahlo, Jasmin;
    • Robrecht, Sandra;
    • Fischer, Kirsten;
    • Herling, Carmen D.;
    • Hoechstetter, Manuela;
    • Fink, Anna‐Maria;
    • Tresckow, Julia;
    • Langerbeins, Petra;
    • Cramer, Paula;
    • Stilgenbauer, Stephan;
    • Wendtner, Clemens M.;
    • Eichhorst, Barbara;
    • Hallek, Michael;
    • Goede, Valentin
    Publication type:
    Article
    22
    23
    24

    Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase III trial.

    Published in:
    British Journal of Haematology, 2012, v. 159, n. 1, p. 67, doi. 10.1111/bjh.12000
    By:
    • Knauf, Wolfgang U.;
    • Lissitchkov, Toshko;
    • Aldaoud, Ali;
    • Liberati, Anna M.;
    • Loscertales, Javier;
    • Herbrecht, Raoul;
    • Juliusson, Gunnar;
    • Postner, Gerhard;
    • Gercheva, Liana;
    • Goranov, Stefan;
    • Becker, Martin;
    • Fricke, Hans-Joerg;
    • Huguet, Francoise;
    • Del Giudice, Ilaria;
    • Klein, Peter;
    • Merkle, Karlheinz;
    • Montillo, Marco
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34

    Author Correction: Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia.

    Published in:
    2023
    By:
    • Al-Sawaf, Othman;
    • Zhang, Can;
    • Jin, Hyun Yong;
    • Robrecht, Sandra;
    • Choi, Yoonha;
    • Balasubramanian, Sandhya;
    • Kotak, Alex;
    • Chang, Yi Meng;
    • Fink, Anna Maria;
    • Tausch, Eugen;
    • Schneider, Christof;
    • Ritgen, Matthias;
    • Kreuzer, Karl-Anton;
    • Chyla, Brenda;
    • Paulson, Joseph N.;
    • Pallasch, Christian P.;
    • Frenzel, Lukas P.;
    • Peifer, Martin;
    • Eichhorst, Barbara;
    • Stilgenbauer, Stephan
    Publication type:
    Correction Notice
    35

    Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37648-w
    By:
    • Al-Sawaf, Othman;
    • Zhang, Can;
    • Jin, Hyun Yong;
    • Robrecht, Sandra;
    • Choi, Yoonha;
    • Balasubramanian, Sandhya;
    • Kotak, Alex;
    • Chang, Yi Meng;
    • Fink, Anna Maria;
    • Tausch, Eugen;
    • Schneider, Christof;
    • Ritgen, Matthias;
    • Kreuzer, Karl-Anton;
    • Chyla, Brenda;
    • Paulson, Joseph N.;
    • Pallasch, Christian P.;
    • Frenzel, Lukas P.;
    • Peifer, Martin;
    • Eichhorst, Barbara;
    • Stilgenbauer, Stephan
    Publication type:
    Article
    36

    Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37648-w
    By:
    • Al-Sawaf, Othman;
    • Zhang, Can;
    • Jin, Hyun Yong;
    • Robrecht, Sandra;
    • Choi, Yoonha;
    • Balasubramanian, Sandhya;
    • Kotak, Alex;
    • Chang, Yi Meng;
    • Fink, Anna Maria;
    • Tausch, Eugen;
    • Schneider, Christof;
    • Ritgen, Matthias;
    • Kreuzer, Karl-Anton;
    • Chyla, Brenda;
    • Paulson, Joe;
    • Pallasch, Christian P.;
    • Frenzel, Lukas P.;
    • Peifer, Martin;
    • Eichhorst, Barbara;
    • Stilgenbauer, Stephan
    Publication type:
    Article
    37
    38
    39
    40
    42

    Primary ureteral leiomyosarcoma in a dog.

    Published in:
    Australian Veterinary Journal, 2017, v. 95, n. 3, p. 68, doi. 10.1111/avj.12538
    By:
    • Yap, FW;
    • Huizing, XB;
    • Rasotto, R;
    • Bowlt‐Blacklock, KL
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50